BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 14728804)

  • 21. Engineering of N-glycosylation of hepatitis C virus envelope protein E2 enhances T cell responses for DNA immunization.
    Li P; Wan Q; Feng Y; Liu M; Wu J; Chen X; Zhang XL
    Vaccine; 2007 Feb; 25(8):1544-51. PubMed ID: 17055129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis C virus E2 and CD81 interaction may be associated with altered trafficking of dendritic cells in chronic hepatitis C.
    Nattermann J; Zimmermann H; Iwan A; von Lilienfeld-Toal M; Leifeld L; Nischalke HD; Langhans B; Sauerbruch T; Spengler U
    Hepatology; 2006 Oct; 44(4):945-54. PubMed ID: 17006905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selection of peptides binding to HCV e2 and inhibiting viral infectivity.
    Hong HW; Lee SW; Myung H
    J Microbiol Biotechnol; 2010 Dec; 20(12):1769-71. PubMed ID: 21193836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peptide mimotopes of rabies virus glycoprotein with immunogenic activity.
    Houimel M; Dellagi K
    Vaccine; 2009 Jul; 27(34):4648-55. PubMed ID: 19520204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Signal sequences modulate the immunogenic performance of human hepatitis C virus E2 gene.
    Sominskaya I; Alekseeva E; Skrastina D; Mokhonov V; Starodubova E; Jansons J; Levi M; Prilipov A; Kozlovska T; Smirnov V; Pumpens P; Isaguliants MG
    Mol Immunol; 2006 May; 43(12):1941-52. PubMed ID: 16442623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding of hepatitis C virus E2 glycoprotein to CD81 does not correlate with species permissiveness to infection.
    Meola A; Sbardellati A; Bruni Ercole B; Cerretani M; Pezzanera M; Ceccacci A; Vitelli A; Levy S; Nicosia A; Traboni C; McKeating J; Scarselli E
    J Virol; 2000 Jul; 74(13):5933-8. PubMed ID: 10846074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Selection of the peptides specifically binding to hepatoma by using phage display in vivo].
    Du B; Yu J; Zhou ZL; Zhang P; Yu M; Qian M
    Zhonghua Zhong Liu Za Zhi; 2005 Nov; 27(11):645-7. PubMed ID: 16438882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression and characterization of a minimal hepatitis C virus glycoprotein E2 core domain that retains CD81 binding.
    McCaffrey K; Boo I; Poumbourios P; Drummer HE
    J Virol; 2007 Sep; 81(17):9584-90. PubMed ID: 17581991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The construction and primary screening of a phage display library of HCV C and E1 genes evolved with an artificial pattern].
    Zhao FT; Jia ZS; Li JG; Wang CY; Wei X; Li GY; Bai XF
    Zhonghua Gan Zang Bing Za Zhi; 2006 Sep; 14(9):666-9. PubMed ID: 16995980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of a conserved linear B-cell epitope at the N-terminus of the E2 glycoprotein of Classical swine fever virus by phage-displayed random peptide library.
    Peng WP; Hou Q; Xia ZH; Chen D; Li N; Sun Y; Qiu HJ
    Virus Res; 2008 Aug; 135(2):267-72. PubMed ID: 18485511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of peptides that bind hepatitis C virus envelope protein E2 and inhibit viral cellular entry from a phage-display peptide library.
    Lü X; Yao M; Zhang JM; Yang J; Lei YF; Huang XJ; Jia ZS; Ma L; Lan HY; Xu ZK; Yin W
    Int J Mol Med; 2014 May; 33(5):1312-8. PubMed ID: 24573486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Host cell responses induced by hepatitis C virus binding.
    Fang X; Zeisel MB; Wilpert J; Gissler B; Thimme R; Kreutz C; Maiwald T; Timmer J; Kern WV; Donauer J; Geyer M; Walz G; Depla E; von Weizsäcker F; Blum HE; Baumert TF
    Hepatology; 2006 Jun; 43(6):1326-36. PubMed ID: 16729312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of glycosaminoglycan-binding sites within hepatitis C virus envelope glycoprotein E2*.
    Olenina LV; Kuzmina TI; Sobolev BN; Kuraeva TE; Kolesanova EF; Archakov AI
    J Viral Hepat; 2005 Nov; 12(6):584-93. PubMed ID: 16255759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Epitope mapping of antigenic determinants of hepatitis C virus proteins by phage display].
    Rechkina EA; Denisova GF; Masalova OV; Lideman LF; Denisov DA; Lesnova EI; Ataullakhanov RI; Gur'ianova SV; Kushch AA
    Mol Biol (Mosk); 2006; 40(2):357-68. PubMed ID: 16637277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Screening peptides binding specifically to large intestinal cancer LoVo cells from phage random peptide library].
    Liao KX; Yao XQ; Wu CT; Lin F; Wu WL; Zeng SD; Luo YQ; Lei ST
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):986-90. PubMed ID: 18583245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Use of a phage peptide library in mapping the group-specific hemagglutinating domain of alpha-virus glycoprotein E2].
    Kuz'micheva GA; Kuvshinov VN; Razumov IA; Ivanisenko VA; Eroshkin AM; Mishin VP; Ushakova TA; Loktev VB; Il'ichev AA
    Mol Gen Mikrobiol Virusol; 1997; (4):25-9. PubMed ID: 9411217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of hepatitis C virus envelope proteins with exosomes.
    Masciopinto F; Giovani C; Campagnoli S; Galli-Stampino L; Colombatto P; Brunetto M; Yen TS; Houghton M; Pileri P; Abrignani S
    Eur J Immunol; 2004 Oct; 34(10):2834-42. PubMed ID: 15368299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis C virus (HCV): a review of immunological aspects.
    Irshad M; Khushboo I; Singh S; Singh S
    Int Rev Immunol; 2008; 27(6):497-517. PubMed ID: 19065353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of potent and long-lasting CD4 and CD8 T-cell responses against hepatitis C virus by immunization with viral antigens plus poly(I:C) and anti-CD40.
    Zabaleta A; Arribillaga L; Llopiz D; Dotor J; Lasarte JJ; Prieto J; Borrás-Cuesta F; Esteban JI; Quer J; Vayreda F; Sarobe P
    Antiviral Res; 2007 Apr; 74(1):25-35. PubMed ID: 17275104
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD81 binding regions of hepatitis C virus remain conserved after liver transplantation.
    Lyra AC; Fan X; Di Bisceglie AM
    Braz J Infect Dis; 2004 Apr; 8(2):126-32. PubMed ID: 15361990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.